# FDA Inspection 1255201 - CSL Plasma Inc. - October 24, 2024

Source: https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/6b85dc8c-8f24-41aa-9592-6f025492c2a8
Source feed: FDA_Inspections

> FDA Inspection 1255201 for CSL Plasma Inc. on October 24, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1255201
- Company Name: CSL Plasma Inc.
- Inspection Date: 2024-10-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1255201 - 2024-10-24](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/ba8d6455-e917-421a-b328-73e1009da4b9)
- [FDA Inspection 1088692 - 2019-04-18](https://www.keypedia.com/records/fda_inspections/csl-plasma-inc/02c76fc6-31ab-464a-95e1-f038f1b4a730)

Company: https://www.keypedia.com/companies/csl-plasma-inc/64e7a97c-2c96-4b0c-8ce5-b1828e5cb8c6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d